A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Phase 1
392
about 2.6 years
18+
20 sites in AZ, CA, CO +9
What this study is about
This trial is testing different ways to give bimekizumab, either intravenously or subcutaneously. The goal is to see if both methods are safe and move similarly throughout the body over time.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Bimekizumab regimen 1 iv
- 2.Receive Bimekizumab regimen 2 iv
- 3.Take Bimekizumab regimen 3 sc
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
bimekizumab
infusion
Secondary: Occurrence of TEAEs leading to withdrawal of study intervention, Occurrence of treatment-emergent Adverse Events (TEAEs) from Baseline to the end of Safety Follow-Up (SFU) Visit, Occurrence of treatment-emergent Serious Adverse Events (SAEs) from Baseline to the end of SFU Visit
Dermatology